Peter Ten Dijke Selected Research

Peter Ten Dijke Research Topics

Disease

67	Neoplasms (Cancer) 12/2023 - 04/2002
25	Breast Neoplasms (Breast Cancer) 12/2023 - 09/2007
22	Neoplasm Metastasis (Metastasis) 12/2023 - 09/2007
9	Inflammation (Inflammations) 08/2022 - 08/2002
9	Fibrosis (Cirrhosis) 01/2022 - 09/2009
7	Pulmonary Arterial Hypertension 03/2023 - 08/2013
7	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 05/2008
5	Carcinogenesis 01/2021 - 09/2011
4	Hereditary Hemorrhagic Telangiectasia 01/2023 - 09/2009
4	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2020 - 01/2010
3	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 09/2007
3	Bites and Stings (Sting) 08/2023 - 01/2023
3	Hypoxia (Hypoxemia) 03/2023 - 08/2013
3	Colonic Neoplasms (Colon Cancer) 08/2022 - 11/2012
3	Pulmonary Hypertension 01/2022 - 08/2013
3	Adenocarcinoma 01/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 01/2023
2	Lung Neoplasms (Lung Cancer) 12/2023 - 11/2012
2	Vascular Diseases (Vascular Disease) 03/2023 - 09/2009
2	Triple Negative Breast Neoplasms 01/2023 - 01/2020
2	Vascular Malformations 01/2023 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2021
2	Osteoarthritis 11/2021 - 01/2017
2	Hypertrophy 11/2021 - 08/2013
2	Vascular Remodeling 06/2020 - 05/2003
2	Heterotopic Ossification (Ectopic Ossification) 11/2019 - 01/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 11/2017 - 01/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 07/2003
2	Infections 11/2016 - 08/2015
2	Dupuytren Contracture (Dupuytrens Contracture) 01/2014 - 06/2011
2	Telangiectasis (Telangiectasia) 09/2009 - 02/2005
1	Circulating Neoplastic Cells 12/2023
1	Melanoma (Melanoma, Malignant) 05/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023

Drug/Important Bio-Agent (IBA)

28	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2023 - 01/2011
18	Proteins (Proteins, Gene)FDA Link 08/2023 - 08/2002
17	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2023 - 08/2002
13	Phosphotransferases (Kinase)IBA 12/2023 - 09/2011
10	Transforming Growth Factor beta (TGF-beta)IBA 12/2023 - 04/2002
10	CytokinesIBA 05/2023 - 01/2016
7	Activin Receptors (Activin Receptor)IBA 05/2023 - 08/2002
6	Messenger RNA (mRNA)IBA 01/2023 - 08/2002
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2017
5	Immune Checkpoint InhibitorsIBA 08/2023 - 01/2020
5	CarcinogensIBA 10/2022 - 04/2002
5	Bone Morphogenetic Protein ReceptorsIBA 01/2022 - 05/2008
5	Activins (Activin)IBA 01/2017 - 11/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 06/2020
4	Deubiquitinating EnzymesIBA 01/2022 - 01/2016
4	Type I Bone Morphogenetic Protein ReceptorsIBA 06/2021 - 01/2010
4	EndoglinIBA 01/2020 - 02/2005
4	Transcription Factors (Transcription Factor)IBA 11/2019 - 01/2016
4	LigandsIBA 11/2019 - 08/2002
3	VimentinIBA 12/2023 - 09/2007
3	InterferonsIBA 08/2023 - 01/2023
3	GlycosphingolipidsIBA 01/2023 - 01/2020
3	Photosensitizing Agents (Photosensitizers)IBA 08/2022 - 01/2022
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2022 - 01/2022
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 11/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2012
3	CollagenIBA 11/2019 - 01/2017
3	Growth Differentiation Factor 2IBA 01/2018 - 01/2017
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2023 - 08/2013
2	LipidsIBA 08/2023 - 08/2015
2	MonocrotalineIBA 03/2023 - 08/2013
2	Therapeutic UsesIBA 01/2023 - 08/2022
2	activin AIBA 01/2023 - 11/2019
2	Long Noncoding RNAIBA 01/2023 - 01/2023
2	TNF Receptor-Associated Factor 4IBA 10/2022 - 09/2013
2	Phenobarbital (Luminal)FDA Link 10/2022 - 09/2007
2	Oxygen (Dioxygen)IBA 05/2022 - 11/2011
2	Cadherins (E-Cadherin)IBA 01/2022 - 09/2007
2	NestinIBA 01/2022 - 10/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 10/2011
2	Polysaccharides (Glycans)IBA 01/2021 - 01/2020
2	Tacrolimus (Prograf)FDA LinkGeneric 11/2020 - 08/2013
2	Epidermal Growth Factor (EGF)IBA 01/2020 - 11/2019
2	Cytostatic AgentsIBA 11/2019 - 01/2016
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018 - 01/2016
2	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2017 - 01/2017
2	CateninsIBA 01/2016 - 05/2011
2	IntegrinsIBA 02/2015 - 02/2012
2	Bone Morphogenetic Protein 7IBA 02/2012 - 09/2007
2	Glycogen Synthase KinasesIBA 09/2011 - 05/2011
1	EnzymesIBA 01/2024
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 12/2023
1	Amiloride (Midamor)FDA LinkGeneric 12/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2023
1	Immunomodulating AgentsIBA 08/2023
1	herboxidieneIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023

Therapy/Procedure

27	Therapeutics 12/2023 - 08/2011
9	Immunotherapy 08/2023 - 01/2019
6	Drug Therapy (Chemotherapy) 01/2023 - 11/2012
4	Photochemotherapy (Photodynamic Therapy) 01/2023 - 01/2022
4	Transplantation 01/2022 - 01/2017
3	Radiotherapy 01/2022 - 02/2009
2	Lasers (Laser) 05/2022 - 09/2007
2	Ligation 01/2016 - 07/2003